Release Date: 28/07/11 16:50 Summary: Appendix 4C - quarterly Price Sensitive: Yes Download Document 39.04KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%